CLRB going down?
NASDAQ:CLRB Cellectar Biosciences, Inc
CLRB has a buy rating on Zacks Rank, but it has poor financial. Based on my experience (or lack of) studying the graph, I expect the stock will drop in the future. At the moment the stock is $4.08.
The stock briefly reached $4.76 before dropping to $4.11 in a matter of minutes. In the hindsight, I wish I took the trade
I am puzzled because on tradingview the stock appears to have reached a peak of around $4.27, while on Interactive Brokers one minute chart, the peak was at $4.76. My idea for CLRB had the entry price at $4.77, which was very close to the entry price listed on IB. Maybe the transaction volume between $4.27 and $4.76 was very small.